NeuOrphan is developing a drug, currently in the preclinical stage of development, that aims to protect the central nervous system from inflammatory damage and promote repair through remyelination - addressing the unmet medical need in patients living with multiple sclerosis progression.
Employees
1-10Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
